Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 5, 2007

LGC to Market Human Genomic Reference Controls in India and Europe

  • LGC Promochem entered into an agreement with Gentris for the marketing and distribution of GentriSure range of Human Genomic Reference Controls (HGRC) in Europe and India.

    The GentriSure products offer highly characterized controls for a variety of key genetic polymorphisms. Currently available controls contain polymorphisms for CYP2D6, CYP2C19, CYP2C9, and VKORC1 genes.

    The controls are isolated from B-lymphoblastoids derived from individual donors. DNA sequences are verified using bi-directional sequencing. There are no artificial DNA sequences introduced to the cell lines so the controls are virtually identical to genomic DNA isolated from typical patient samples.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »